SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 2.34 |
| Enterprise Value ($M) | 2.63 |
| Book Value ($M) | 3.73 |
| Book Value / Share | 3.64 |
| Price / Book | 0.63 |
| NCAV ($M) | -5.51 |
| NCAV / Share | -5.37 |
| Price / NCAV | -0.42 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.74 |
| Return on Assets (ROA) | -0.63 |
| Return on Equity (ROE) | n/a |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 0.19 |
| Current Ratio | 0.19 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 1.23 |
| Assets | 10.47 |
| Liabilities | 6.74 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Nonrecurring Common Control Intra Entity Transactions Description | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Armistice Capital, Llc | 4.99 | -95.15 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 16,877 | 64,445 | 26.19 | |
| 35,133 | 105,259 | 33.38 | |
| 6,500 | 37,132 | 17.51 | |
| 13,352 | 50,622 | 26.38 | |
| 15,780 | 88,193 | 17.89 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| ARTL – Artelo Biosciences, Inc. | ASNS – Actelis Networks, Inc. |
| ASRT – Assertio Holdings, Inc. | ATOS – Atossa Therapeutics, Inc. |
| ATXI – Avenue Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io